Genomic and non-genomic actions of progestogens in the breast

Journal of Steroid Biochemistry and Molecular Biology

Volumn 142, Issue , 2014, Pages 62-67

  Mueck, A O ^a   Ruan, X ^b   Seeger, H ^a   Fehm, T ^c   Neubauer, H ^c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; DROSPIRENONE; ETONOGESTREL; GESTAGEN; GLUCOCORTICOID RECEPTOR; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MINERALOCORTICOID RECEPTOR; NORETHISTERONE ACETATE; PROGESTERONE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; TRIMEGESTONE;

ACROSOME REACTION; ANTIPROLIFERATIVE ACTIVITY; BINDING AFFINITY; BIOLOGICAL ACTIVITY; BREAST; BREAST CANCER; BREAST CANCER CELL LINE; BREAST EPITHELIUM; CANCER THERAPY; CELL CYCLE; CELL PROLIFERATION; CONTRACEPTION; ESTROGEN THERAPY; GENE ACTIVATION; GENE EXPRESSION; GENOMICS; HUMAN; NONHUMAN; OOCYTE MATURATION; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; RNA SYNTHESIS; UPREGULATION;

BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MEMBRANE PROTEINS; POSTMENOPAUSE; PROGESTINS; RECEPTORS, PROGESTERONE; RISK; WOMEN'S HEALTH;

EID: 84899938577     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.08.011     Document Type: Review

References (82)

1. World Cancer Report International Agency for Research on Cancer 2008 http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900 (retrieved 2011-02-263)
2. Breast cancer: prevention and control, World Health Organization. http://www.who.int/cancer/detection/breastcancer/en/index1.html.
3. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women JAMA 288 2002 321 333
4. Million Women Study Collaborators Breast cancer and hormone replacement therapy in the Million Women Study Lancet 362 2003 419 427
5. A. Fournier, F. Berrino, and F. Clavel-Chapelon Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study Breast Cancer Res. Treat. 107 2008 103 111
6. The Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy JAMA 291 2004 1701 1712
7. O.M. Conneely, B. Maulac-Jeticevic, and J.P. Lydon Progesterone-dependent regulation of female reproductive activity by two-distinct progesterone receptor isoforms Steroids 68 2003 771 778
8. F.Z. Stanczyk, J.P. Hapgood, S. Winer, and D.R. Mishell Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects Endocr. Rev. 2012 (first published ahead of print 13.12.12) 10.1210/er.2012-1008
9. M. Aupperlee, A. Kariagina, J. Osuch, and S.Z. Haslam Progestins and breast cancer Breast Dis. 24 2006 37 57
10. M.E. Meyer, C. Quirin-Stricker, T. Lerouge, M.T. Bocquel, and H. Gronemeyer A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms J. Biol. Chem. 267 1992 10882 10887
11. C.A. Sartorius, M.Y. Melville, A.R. Hovland, L. Tung, G.S. Takimoto, and K.B. Horwitz A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform Mol. Endocrinol. 8 1994 1347 1360
12. B. Mulac-Jericevic, R.A. Mullinax, F.J. DeMayo, J.P. Lydon, and O.M. Conneely Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform Science 289 2000 1751 1754
13. B. Mulac-Jericevic, J.P. Lydon, F.J. DeMayo, and O.M. Conneely Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform Proc. Natl. Acad. Sci. U.S.A. 100 2003 9744 9749
14. G. Shyamala, X. Yang, G. Silberstein, M.H. Barcellos-Hoff, and E. Dale Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands Proc. Natl. Acad. Sci. U.S.A. 95 1998 696 701
15. G. Shyamala, X. Yang, R.D. Cardiff, and E. Dale Impact of progesterone receptor on cell-fate decisions during mammary gland development Proc. Natl. Acad. Sci. U.S.A. 97 2000 3044 3049
16. B.M. Jacobsen, S.A. Schittone, J.K. Richer, and K.B. Horwitz Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology Mol. Endocrinol. 19 2005 574 587
17. C.A. Lange, J.K. Richer, and K.B. Horwitz Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals Mol. Endocrinol. 13 1999 829 836
18. Z. Zhang, S.G. Lundeen, Y. Zhu, J.M. Carver, and R.C. Winneker In vitro characterization of trimegestone: a new potent and selective progestin Steroids 65 2000 637 643
19. D. Philibert, F. Bouchoux, M. Degryse, D. Lecaque, F. Petit, and M. Gaillard The pharmacological profile of a novel norpregnance progestin (trimegestone) Gynecol. Endocrinol. 13 1999 316 326
20. E.W. Bergink, F. van Meel, E.W. Turpijn, and J. van der Vies Binding of progestagens to receptor proteins in MCF-7 cells J. Steroid Biochem. 19 1983 1563 1570
21. P.D. Feil, and C.W. Bardin The use of medroxyprogesterone acetate to study progestin receptors in immature, pregnant, and adult rabbit uterus Adv. Exp. Med. Biol. 117 1979 241 254
22. P.J. Selman, J. Wolfswinkel, and J.A. Mol Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog Steroids 61 1996 133 137
23. G.H. Deckers, W.G. Schoonen, and H.J. Kloosterboer Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals J. Steroid Biochem. Mol. Biol. 74 2000 83 92
24. B.A. Chavez, F. Vilchis, A.E. Perez, G.A. Garcia, I. Grillasca, and G. Perez-Palacios Stereospecificity of the intracellular binding of norethisterone and its A-ring reduced metabolites J. Steroid Biochem. 22 1985 121 126
25. K. Kontula, O. Janne, R. Vihko, E. de Jager, J. de Visser, and F. Zeelen Progesteronebinding proteins: in vitro binding and biological activity of different steroidal ligands Acta Endocrinol. 78 1975 574 592
26. U. Fuhrmann, R. Krattenmacher, E.P. Slater, and K.H. Fritzemeier The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential Contraception 54 1996 243 251
27. R. Krattenmacher Drospirenone: pharmacology and pharmacokinetics of a unique progestogen Contraception 62 2000 29 38
28. H.J. Kloosterboer, C.A. Vonk-Noordegraaf, and E.W. Turpijn Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives Contraception 38 1988 325 332
29. W.G.E.J. Schoonen, R. Dijkema, R.J.H. de Ries, J.L. Wagenaars, J.W.H. Joosten, M.E. de Gooyer, G.H. Deckers, and H.J. Kloosterboer Human progesterone receptor A and B isoforms in CHO cells. II. Comparison of binding, transactivation and ed50 values of several synthetic (anti)progestagens in vitro in CHO and MCF-7 cells and in vivo in rabbits and rats J. Steroid Biochem. Mol. Biol. 64 1998 157 170
30. R. Ghatge, B. Jacobsen, S. Schittone, and K. Horwitz The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells Breast Cancer Res. 7 2005 R1036 R1050
31. J.D. Bray, S. Jelinsky, R. Ghatge, J.A. Bray, C. Tunkey, K. Saraf, B.M. Jacobsen, J.K. Richer, E.L. Brown, R.C. Winneker, K.B. Horwitz, and C.R. Lyttle Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells J. Steroid Biochem. Mol. Biol. 97 2005 328 341
32. N.L. Moore, T.E. Hickey, L.M. Butler, and W.D. Tilley Multiple nuclear receptor signalling pathways mediate the actions of synthetic progestins in target cells Mol. Cell. Endocrinol. 397 2012 60 70
33. Y.J. Topper, and C.S. Freeman Multiple hormone interactions in the developmental biology of the mammary gland Physiol. Rev. 60 1980 1049 1106
34. C.L. Clarke, and R.L. Sutherland Progestin regulation of cellular proliferation Endocr. Rev. 11 1990 266 301
35. M.J. McManus, and C.W.C.W. Welsch The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice Cancer 54 1984 1920 1927
36. I.J. Laidlaw, R.B. Clarke, A. Howell, A.W.M.C. Owen, C.S. Potten, and E. Anderson The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone Endocrinology 136 1995 164 171
37. A. Gompel, C. Malet, P. Spritzer, J.-P. Lalardrie, F. Kutten, and P. Mauvais-Jarvis Progestin effect on cell proliferation and 17b-hydroxysteroid dehydrogenase activity in normal human breast cells in culture J. Clin. Endocrinol. Metab. 63 1986 1174 1180
38. B. van der Burg, E. Kalkhoven, L. Isbrücker, and S.W. de Laat Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions J. Steroid Biochem. Mol. Biol. 42 1992 457 465
39. W.H. Catherino, M.H. Jeng, and V.C. Jordan Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism Br. J. Cancer 67 1993 945 952
40. W.G.E.J. Schoonen, J.W.H. Joosten, and H.J. Kloosterboer Effects of two classes of progestins, Pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: 1.MCF-7 cell lines J. Steroid Biochem. Mol. Biol. 55 1995 423 437
41. V. Cappelletti, P. Miodini, L. Fioravanti, and G. DiFronzo Effect of progestin treatment on estradiol- and growth factor-stimulated breast cancer cell lines Anticancer Res. 15 1995 2551 2556
42. E.A. Krämer, H. Seeger, B. Krämer, D. Wallwiener, and A.O. Mueck The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells Eur. J. Obstet. Gynecol. Reprod. 27 2006 139 141
43. R.W. Schatz, A.M. Soto, and C. Sonnenschein Effects of interaction between estradiol-17 beta and progesterone on the proliferation of cloned breast tumor cells (MCF-7 and T47D) J. Cell Physiol. 124 1985 386 390
44. M.H. Jeng, C.J. Parker, and V.C. Jordan Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation Cancer Res. 52 1992 6539 6546
45. C. Lippert, H. Seeger, D. Wallwiener, and A.O. Mueck The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment Eur. J. Gynaecol. Oncol. 22 2001 331 335
46. R.J. Santen, R. Xinde Song, R. McPherson, R. Kumar, L. Adam, M.H. Jeng, and W. Yue The role of mitogen-activated protein (MAP) kinase in breast cancer J. Steroid Biochem. Mol. Biol. 80 2002 239 256
47. E.K. Lobenhofer, G. Huper, J.D. Iglehart, and J.R. Marks Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis Cell Growth Differ. 11 2000 99 110
48. W. Yue, J.-P. Wang, M. Conaway, S. Masamura, Y. Li, and R. Santen Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol Endocrinology 143 2002 3221 3229
49. A.M. Gaben, C. Saucier, M. Bedin, G. Redeuilh, and J. Mester Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase Mol. Endocrinol. 18 2004 2700 2713
50. C.A. Lange, J.K. Richer, T. Shen, and K.B. Horwtiz Convergence of progesterone and epidermal growth factor signalling in breast cancer J. Biol. Chem. 273 1998 31308 31316
51. M. Alkhalaf, and A.M. El-Mowafy Overexpression of wild-type p53 gene renders MCF-7 breast cancer cells more sensitive to the antiproliferative effect of progesterone J. Endocrinol. 179 2003 55 62
52. X.D. Fu, M.S. Giretti, L. Goglia, M.I. Flamini, A.M. Sanchez, C. Baldacci, S. Garibaldi, R. Sitruk-Ware, A.R. Genazzani, and T. Simoncini Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion BMC Cancer 8 2008 166
53. S.M. Hyder, L. Murthy, and G.M. Stancel Progestin regulation of vascular endothelial growth factor in human breast cancer cells Cancer Res. 58 1998 392 395
54. R.J. Pietras, and C.M. Szego Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells Nature 265 1977 69 72
55. M. Lieberherr, and B. Grosse Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein J. Biol. Chem. 269 1994 7217 7223
56. Z. Guo, W.P. Benten, J. Krucken, and F. Wunderlich Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptor-free macrophages J. Biol. Chem. 277 2002 29600 29607
57. W.P. Benten, M. Lieberherr, G. Giese, C. Wrehlke, O. Stamm, C.E. Sekeris, H. Mossmann, and F. Wunderlich Functional testosterone receptors in plasma membranes of T cells FASEB J. 13 1999 123 133
58. M. Kampa, E.A. Papakonstanti, A. Hatzoglou, E.N. Stathopoulos, C. Stournaras, and E. Castanas The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton FASEB J. 16 2002 1429 1431
59. L. Figueroa-Valverde, H. Luna, C. Castillo-Henkel, O. Munoz-Garcia, T. Morato-Cartagena, and G. Ceballos-Reyes Synthesis and evaluation of the cardiovascular effects of two, membrane impermeant, macromolecular complexes of dextran-testosterone Steroids 67 2002 611 619
60. J. Tesarik, J. Moos, and C. Mendoza Stimulation of protein tyrosine phosphorylation by a progesterone receptor on the cell surface of human sperm Endocrinology 133 1993 328 335
61. B. Grosse, M. Kachkache, V. Le Mellay, and M. Lieberherr Membrane signalling and progesterone in female and male osteoblasts. I. Involvement of intracellular Ca(2+), inositol trisphosphate, and diacylglycerol, but not cAMP J. Cell. Biochem. 79 2000 334 345
62. V. Machelon, F. Nome, B. Grosse, and M. Lieberherr Progesterone triggers rapid transmembrane calcium influx and/or calcium mobilization from endoplasmic reticulum, via a pertussisinsensitive G-protein in granulosa cells in relation to luteinization process J. Cell. Biochem. 61 1996 619 628
63. C.P. Bagowski, J.W. Myers, and J.E. Ferrell The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes J. Biol. Chem. 276 2001 37708 37714
64. Y. Zhu, J. Bond, and P. Thomas Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor Proc. Natl. Acad. Sci. U.S.A. 100 2003 2237 2242
65. Y. Zhu, C.D. Rice, Y. Pang, M. Pace, and P. Thomas Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes Proc. Natl. Acad. Sci. U.S.A. 100 2003 2231 2236
66. D. Gerdes, M. Wehling, B. Leube, and E. Falkenstein Cloning and tissue expression of two putative steroid membrane receptors Biol Chem. 379 1998 907 911
67. M.A.M.A. Cahill Progesterone receptor membrane component 1: an integrative review J. Steroid Biochem. Mol. Biol. 105 2007 16 36
68. L. Engmann, R. Losel, M. Wehling, and J.J. Peluso Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism J. Clin. Endocrinol. Metab. 91 2006 4962 4968
69. R. Losel, S. Breiter, M. Seyfert, M. Wehling, and E. Falkenstein Classic and non-classic progesterone receptors are both expressed in human spermatozoa Horm. Metab. Res. 37 2005 10 14
70. G. Crudden, R. Loesel, and R.J. Craven Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors Tumour Biol. 26 2005 142 146
71. S.F. Ji, A.G. Wu, and H.F. Yang Expression of progesterone receptor membrane component-1 is associated with the malignant phenotypes of breast cancer Nan Fang Yi Ke Da Xue Xue Bao 32 2012 635 638
72. M.W. Causey, L.J. Huston, D.M. Harold, C.J. Charaba, D.L. Ippolito, Z.S. Hoffer, T.A. Brown, and J.D. Stallings Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging J. Surg. Res. 171 2011 615 622
73. H. Neubauer, G. Adam, H. Seeger, A.O. Mueck, E. Solomayer, D. Wallwiener, M.A. Cahill, and T. Fehm Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells Climacteric 3 2009 230 239
74. J.J. Peluso, A. Gawkowska, X. Liu, T. Shioda, and J.K. Pru Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice Endocrinology 150 2009 4846 4854
75. M. Swiatek-De Lange, A. Stampfl, S.M. Hauck, H. Zischka, C.J. Gloeckner, C.A. Deeg, and M.M. Ueffing Membrane-initiated effects of progesterone on calcium dependent signaling and activation of VEGF gene expression in retinal glial cells Glia 55 2007 1061 1073
76. H. Neubauer, R. Chen, and H. Schneck New insight on a possible mechanism of progestogens in terms of breast cancer risk Horm. Mol. Biol. Clin. Invest. 6 2011 185 192
77. X. Ruan, H. Neubauer, Y. Yang, H. Schneck, S. Schultz, T. Fehm, M.A. Cahill, H. Seeger, and A.O. Mueck Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells Climacteric 15 2012 467 472
78. X. Ruan, H. Schneck, S. Schultz, T. Fehm, M.A. Cahill, H. Seeger, R. Chen, Q. Yu, A.O. Mueck, and H. Neubauer Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells Gynecol. Endocrinol. 28 2012 863 866
79. H.J. Rohe, I.S. Ahmed, K.E. Twist, and R.J. Craven PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling. P450 activation and drug binding Pharmacol. Ther. 121 January (1) 2009 14 19
80. J.J. Peluso, A. Yuan, X. Liu, and V. Lodde Plasminogen activator inhibitor 1 RNA-binding protein interacts with progesterone receptor membrane component 1 to regulate progesterone's ability to maintain the viability of spontaneously immortalized granulosa cells and rat granulosa cells Biol. Reprod. 88 January (1) 2013 20 10.1095/biolreprod.112.103036 (Print 2013 January)
81. ®: a randomised, single-blind, triple cross-over bioavailability study in menopausal women Maturitas 18 1994 229 238
82. F.Z. Stanczyk, P.F. Brenner, D.R. Mishell, A. Ortiz, E.K.E. Gentzschein, and Goebelsmann U: A radioimmunoassay for norethindrone (NET): measurement of serum net concentrations following ingestion of NET-containing oral contraceptive steroids Contraception 18 1978 615 633